Cancer

[title]
  • Professor, Division of Environmental Health Sciences, School of Public Health

Timothy Church, PhD, is a professor in the Division of Environmental Health Sciences in the School of Public Health. A member of the Masonic Cancer Center’s Screening, Prevention, Etiology and Cancer Survivorship Research Program, his expertise is in cancer screening, colorectal cancer, medical device evaluation, biostatistics, epidemiologic methods, and clinical trial design. Dr. Church is currently leading multiple trials and studies regarding colorectal, prostate, lung, and ovarian cancer, and has recently established a registry for Parkinson’s Disease research. His primary research interests include clinical trials and epidemiological studies related to screening for and prevention of multiple cancers, as well as the development of biostatistical and epidemiologic methods. He teaches Occupational and Environmental Epidemiology and a doctoral seminar on causal inference.    

[title]
  • Professor of Medicine, Medical School
  • Division of Hematology, Oncology and Transplantation, Department of Medicine

Edward Greeno, MD, is a professor in the Department of Medicine's Division of Hematology, Oncology and Transplantation. Dr. Greeno is the Medical Director of the Masonic Cancer Clinic at the University of Minnesota, and Executive Medical Director for University of Minnesota Cancer Care,  with expertise in the development and management of care systems for cancer patients. He is a member of the Executive Committee of the Masonic Cancer Center. His primary interest is in treatment of gastrointestinal malignancies, including rare tumor types such as neuroendocrine tumors and appendix cancer. He is an investigator on numerous therapeutic trials for gastrointestinal cancers ranging from large multinational trials which have led to the approval of new treatments, to first in human trials of new agents developed at the University of Minnesota.

Expert in:
[title]
  • Professor of Medicine, Medical School
  • Division of Hematology, Oncology and Transplantation, Department of Medicine
  • Co-Chair, Tumor Microenvironment Program, Masonic Cancer Center
  • Co-Chair, Molecular and Cellular Engineering Program, Institute for Engineering in Medicine

Kalpna Gupta, PhD, is a professor of Medicine in the Division Hematology, Oncology, and Transplantation. Dr. Gupta's main research interests include pain and vascular biology as well as molecular mechanisms underlying the tumor microenvironment and pain. Her work is focused on the mechanisms of pain and pain therapy with opioids, cannabinoids, and evolving novel therapies. Her laboratory developed the paradigm that opioids used for pain influence the tumor microenvironment and promote cancer progression. Another major focus of her laboratory is studying pain in sickle cell disease and discovering novel targets to treat chronic and acute pain. Currently her laboratory is deeply involved in basic and translational research leading to clinical outcomes on improving analgesia in cancer and sickle cell disease. Gupta is the co-leader of the Masonic  Cancer Center’s Tumor Microenvironment Research Program.   

Expert in:
[title]
  • Assistant Professor of Medicine, Medical School
  • Division of Hematology, Oncology and Transplantation, Department of Medicine
  • Masonic Cancer Center

Emil Lou, MD, PhD, is an Assistant Professor and gastrointestinal oncologist at the Masonic Cancer Center. Lou also runs the Lou Lab at the U of M where his main research interest involves investigating tumor heterogeneity and intercellular communication in a spectrum of invasive and aggressive solid tumor malignancies. Lou's research efforts focus on investigating the biology of cancer cells as they relate to invasion, progression, tumor recurrence, and chemotherapy resistance. Clinical interests and areas of expertise include: pancreatic cancer, esophageal cancer, gastric cancer, colorectal cancer, cancer metastasis, solid tumor metastasis to the brain, and primary brain tumors. Lou is a member of the Masonic  Cancer Center’s Tumor Microenvironment Research Program. Lou also has expertise in use of social media in clinical oncology, cancer research, and patient advocacy, through use of Twitter and other online forums. He was a participant in the AACR-ABC News Live Stream "Breakthroughs in Cancer Research" from the 2015 AACR Annual Meeting which can be viewed here.    

Expert in:
[title]
  • Associate Professor, Division of Environmental Health Sciences, School of Public Health

Jeff Mandel, MD, MPH, is an associate professor in the School of Public Health's Division of Environmental Health Sciences. Dr. Mandel is an occupational physician and epidemiologist. He is an expert regarding the health issues of various environmental and workplace exposures. Dr. Mandel has served as an advisory committee member for the screening of vermiculite/asbestos-exposed people in Northeast Minneapolis. He has also served as a task force member for the screening of former Conwed workers with asbestos exposure. Both of these positions were held in conjunction with the Minnesota Department of Health. Dr. Mandel’s research interests are occupational cancer risk from low-dose exposures, exposure to persistent materials and severity of chronic diseases and exposure-disease relationships. 

[title]
  • Professor of Medicine, Division of Hematology, Oncology and Transplantation
  • Department of Medicine, Medical School
  • Deputy Director, Masonic Cancer Center
  • Roger L. and Lynn C. Headrick Chair in Cancer Therapeutics
  • Associate Scientific Director, Molecular and Cellular Therapeutics

Jeffrey S. Miller, MD, is currently a Professor of Medicine at the University of Minnesota.  He is the Deputy Director of the Masonic Cancer Center, University of Minnesota. Dr. Miller has more than 20 years of experience studying the biology of NK cells and other immune effector cells and their use in clinical immunotherapy with over 170 peer-reviewed publications.  He is a member of numerous societies such as the American Society of Hematology, the American Association of Immunologists, and a member of the American Society of Clinical Investigation since 1999.  He serves on the editorial board for Blood and is a reviewer for a number of journals and NIH grants. 

Expert in:
[title]
  • Professor of Oncology and Comparative Medicine, Department of Veterinary Clinical Sciences
  • Director, Animal Cancer Care and Research Program, College of Veterinary Medicine

Jaime Modiano, VMD, PhD, is the director of the Animal Cancer Care and Research Program at the College of Veterinary Medicine, as well as a professor of Oncology and Comparative Medicine, and Veterinary Clinical Sciences. Modiano is the head researcher of his Modiano lab where he focuses on understanding mechanisms of neoplastic transformation and tumor progression. A member of the Masonic Cancer Center’s Genetic Mechanisms of Cancer Research Program, his research interests include: cancer genetics, cancer immunology and tumor-microenvironment interactions, diagnostic development and therapeutic development. 

Pages